Lv54
1338 积分 2024-11-01 加入
Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China
1小时前
已关闭
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker
1天前
已完结
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations
1天前
已完结
Dual-payload ADCs move into first oncology clinical trials
2天前
已完结
Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion
8天前
已完结
Selective P−C(sp3) Bond Cleavage and Radical Alkynylation of α‐Phosphorus Alcohols by Photoredox Catalysis
8天前
已完结
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
9天前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
9天前
已完结
A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs
11天前
已完结
Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors
14天前
已完结
皖公网安备34019202002308
